Laxmi Organic Industries Ltd Q2FY26 – The Solvent Samurai Strikes Again: ₹700 Cr Revenue, ₹11 Cr Profit, and a Dahej Dream Worth ₹1,100 Cr!
1. At a Glance
Laxmi Organic Industries Ltd, the 35-year-old warrior of solvents and specialty chemistry, just dropped its Q2FY26 results — and let’s just say, the numbers are less Breaking Bad, more “Breaking Even.” The company clocked ₹700 crore in sales and ₹11 crore PAT, marking a -9% YoY revenue dip and a -61% YoY profit fall. The operating margin? 7% — not terrible, but not exactly chemistry on fire.
With a market cap of ₹5,631 crore and a P/E of 67.5, the stock seems to think it’s in the Pidilite or Navin Fluorine club. Meanwhile, ROE at 5.93% and ROCE at 8.56% say, “Bro, calm down.” The stock trades at ₹203, a long way from its ₹284 high, but thankfully above the ₹160 “please-hold-your-breath” low.
Still, there’s reason to watch. A ₹1,100 crore capex spree is underway, a Dahej mega-plant is nearing completion, and a proposed merger with Yellowstone Fine Chemicals could finally make their fluorospecialty segment explode faster than an exothermic reaction.
2. Introduction
If the Indian chemicals industry were a Bollywood family drama, Laxmi Organic would be the middle child — reliable, overshadowed, and trying really hard to get noticed while Pidilite and Deepak Nitrite steal the limelight.
Founded in 1989, this Mumbai-based company has grown from making basic acetates to sophisticated Diketene Derivative Products (DDPs) — the stuff that goes into everything from painkillers to paints to pesticides. It’s now a 650+ customer global network spanning 52 countries, with a balance sheet that screams “steady compounder… someday.”
But the short-term story isn’t all rosy. Global demand for acetates has cooled, crude prices and Chinese dumping have squeezed margins, and the “specialty” business hasn’t yet delivered “special” returns. However, management has been doubling down — new capacities, new chemistries, and new geographies.
Will Laxmi’s ₹1,100 crore capex plan finally make it sparkle like Navin Fluorine or remain the quiet “solvent supplier next door”?
3. Business Model – WTF Do They Even Do?
In short: they sell chemicals you’ve probably inhaled without knowing it.
Two Segments. One Mission: Keep industries running (and noses burning).
🧪 Essentials Segment (Mass Market)
Think of it as the company’s bread and butter — or rather, ethanol and acetate. Products: Ethyl Acetate, Acetic Anhydride, Acetaldehyde, n-Butyl Acetate, Ethanol. Uses: Pharma, packaging, industrial coatings, and printing inks. Contribution to EBITDA: 32% (9MFY25)
⚗️ Specialty Segment (High-Margin Science)
Here’s where the “smart chemistry” happens — Ketene, Diketene derivatives, esters, amides, fluorospecialties, and arylides. Customers: Pharma, agrochemicals, pigments, coatings, and even electronics. Contribution to EBITDA: 68% (9MFY25)
Geographical Mix: India – 64% Exports – 36% (America 33%, Europe 21%, Middle East 17%, APAC 16%, China 6%)
So basically, half their molecules end up in your pills, your car paint, or someone’s pesticide spray in Brazil.
4. Financials Overview
Metric (₹ Cr)
Latest Qtr (Sep’25)
YoY Qtr (Sep’24)
Prev Qtr (Jun’25)
YoY %
QoQ %
Revenue
700
771
693
-9.2%
1.0%
EBITDA
37
75
31
-50.7%
19.4%
PAT
11.0
28
21
-60.8%
-47.6%
EPS (₹)
0.40
1.02
0.77
-60.8%
-48.0%
Commentary: Margins have taken a hit thanks to soft solvent prices, higher energy costs, and competitive undercutting from Chinese suppliers. The bright spot? Stable sequential revenue, hinting that the worst of demand contraction might be behind.
5. Valuation Discussion – Fair Value Range Only
Let’s break out the calculators (and a pinch of sarcasm):
A. P/E Method: EPS (TTM) = ₹3.01 Industry P/E = 32 Fair Value = ₹3.01 × 32 = ₹96.3/share
B. EV/EBITDA Method: EV = ₹5,771 Cr EBITDA (TTM) = ₹202 Cr EV/EBITDA = 28.6× (sector avg 18×) Fair EV if normalized = 18×202 = ₹3,636 Cr → ₹130–135/share
C. DCF (Optimistic PSU-style Science): Assuming EBITDA triples by FY28 per guidance, fair range = ₹140–₹170/share
📘 Fair Value Range (educational only): ₹95 – ₹170 per share (This is for educational purposes only
